Clinical Utility of Oxford Cognitive Screen Test to Screen Cognitive Impairment in Post Stroke Patients
Launched by CHA UNIVERSITY · Mar 19, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a tool called the Korean Oxford Cognitive Screen (K-OCS) to see how well it can help identify cognitive problems in people who have had a stroke. The main goals are to confirm that the K-OCS is a reliable and accurate way to detect these issues and to compare its effectiveness with other existing tests. Researchers are currently looking for participants, including adults aged 20 and older who have experienced a stroke at least 72 hours ago. Healthy volunteers over 20 who can live independently are also welcome to participate.
If you join this study, you will undergo assessments using the K-OCS to see how well it works in detecting cognitive impairment after a stroke. Participation is voluntary, and you will receive detailed information about the study before deciding to take part. It's important to know that this trial aims to improve the way we understand and diagnose cognitive issues in stroke patients, which could lead to better care and support in the future.
Gender
All
Eligibility criteria
- For stroke patients 1) Inclusion Criteria:
- • Adults over 20 years of age
- • more than 72 hours elapsed since the onset of stroke symptoms.
- • After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions
- • involved individuals diagnosed with stroke by neurology and rehabilitation medicine specialists based on data acquired from 3T GE Signa System (General Electric, Milwaukee, WI), brain magnetic resonance imaging (MRI), and computed tomography (CT).
- 2) Exclusion Criteria:
- • Who cannot meet the inclusion criteria
- For healthy voluteers 1) Inclusion Criteria:
- • Over 20 years of age
- • A person who is performing an independent daily life
- • A person who voluntarily decides to participate and agrees in writing to abide by the precautions after hearing a detailed explanation of this study and fully understanding it
- 2) Exclusion Criteria:
- • Who cannot meet the inclusion criteria
About Cha University
CHA University is a leading research institution dedicated to advancing medical science and improving patient care through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, CHA University engages in cutting-edge research across various fields, including oncology, cardiology, and regenerative medicine. The university fosters a dynamic environment for clinical research, driven by a commitment to ethical standards and patient safety, ensuring that all trials are conducted with the highest level of scientific rigor. Through its extensive network of healthcare professionals and state-of-the-art facilities, CHA University aims to contribute significantly to the development of new therapies and enhance the understanding of complex medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seongnam Si, Gyeonggi Do, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
: Between November 2020 and April 2022